Healthcare
Live Price
Offline$1.60
+0.00% today
1Y Change
-27.27%
Window
Jun 27, 2025 โ Jun 24, 2026
Coverage: 255 bars ยท Jun 27, 2025 โ Jun 24, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Genscript Biotech Corporation (GNNSF) is a Healthcare stock with a market cap of $3.83B and listed on OTC. The stock last traded around $1.60 and down 27.3% across the available one-year price window (Jun 27, 2025 โ Jun 24, 2026). Baseline metrics include revenue growth of +61.4%, EPS growth of -117.6%, a dividend yield of 0.0%. What stands out right now is revenue +61.4%, EPS -117.6%, free cash flow +434.4% with operating margin 27.3% and ROIC 5.6%. Valuation is more restrained than many high-expectation growth names at price/sales 4.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines GNNSF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
GNNSF
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
GNNSF Max Drawdown
-46.28%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Uses the longest available daily history for GNNSF and SPY.
Next Step
Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.